We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
Cap. Flow
-$915M
Cap. Flow %
-1.97%
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$170M
2
T icon
AT&T
T
+$142M
3
MSFT icon
Microsoft
MSFT
+$136M
4
XLNX
Xilinx Inc
XLNX
+$110M
5
AMZN icon
Amazon
AMZN
+$86.9M

Sector Composition

Rank Sector Weight
1 Technology 31.53%
2 Consumer Discretionary 13.24%
3 Communication Services 9.89%
4 Healthcare 9.39%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARLO icon
1926
Arlo Technologies
ARLO
$1.4B
$167K ﹤0.01%
18,770
-2,322
-11% -$21.3K
DENN
1927
DELISTED
Denny's
DENN
$167K ﹤0.01%
11,610
-1,917
-14% -$29.2K
TWI icon
1928
Titan International
TWI
$516M
$167K ﹤0.01%
11,361
-1,400
-11% -$16.4K
DM
1929
DELISTED
Desktop Metal, Inc.
DM
$167K ﹤0.01%
3,512
-579
-14% -$24.5K
ARR
1930
Armour Residential REIT
ARR
$2.02B
$166K ﹤0.01%
3,964
-489
-11% -$21.8K
UTZ icon
1931
Utz Brands
UTZ
$1.25B
$166K ﹤0.01%
11,216
-1,677
-13% -$26.2K
SXC icon
1932
SunCoke Energy
SXC
$757M
$165K ﹤0.01%
18,485
-2,283
-11% -$18K
AMWL icon
1933
American Well
AMWL
$181M
$163K ﹤0.01%
1,940
-306
-14% -$25.8K
BVS icon
1934
Bioventus
BVS
$799M
$162K ﹤0.01%
11,406
-3,087
-21% -$41.3K
CNDT icon
1935
Conduent
CNDT
$230M
$162K ﹤0.01%
31,473
-5,130
-14% -$25.2K
RES icon
1936
RPC Inc
RES
$1.24B
$162K ﹤0.01%
15,120
-1,872
-11% -$14.9K
MCRB icon
1937
Seres Therapeutics
MCRB
$48M
$161K ﹤0.01%
1,128
-277
-20% -$42.6K
NKTR icon
1938
Nektar Therapeutics
NKTR
$2.39B
$161K ﹤0.01%
1,983
-444
-18% -$65.7K
WNC icon
1939
Wabash National
WNC
$543M
$161K ﹤0.01%
10,873
-1,474
-12% -$26K
IVR icon
1940
Invesco Mortgage Capital
IVR
$776M
$159K ﹤0.01%
6,975
-878
-11% -$21.6K
KRNY icon
1941
Kearny Financial
KRNY
$592M
$159K ﹤0.01%
12,334
-2,487
-17% -$33K
SENS icon
1942
Senseonics Holdings Inc
SENS
$254M
$159K ﹤0.01%
4,052
-670
-14% -$30.7K
KPTI icon
1943
Karyopharm Therapeutics
KPTI
$168M
$158K ﹤0.01%
1,420
-338
-19% -$42.1K
ATEN icon
1944
A10 Networks
ATEN
$2.47B
$157K ﹤0.01%
11,271
-1,859
-14% -$26.1K
NUVB icon
1945
Nuvation Bio
NUVB
$2.24B
$157K ﹤0.01%
29,807
-4,924
-14% -$27.7K
MGNX icon
1946
MacroGenics
MGNX
$235M
$156K ﹤0.01%
17,604
-4,114
-19% -$45.4K
RYTM icon
1947
Rhythm Pharmaceuticals
RYTM
$7B
$155K ﹤0.01%
13,465
-3,242
-19% -$28.5K
HLX icon
1948
Helix Energy Solutions
HLX
$1.46B
$153K ﹤0.01%
31,782
-3,936
-11% -$16.1K
ATEC icon
1949
Alphatec Holdings
ATEC
$1.27B
$152K ﹤0.01%
13,259
-2,189
-14% -$23.7K
DHT icon
1950
DHT Holdings
DHT
$2.97B
$152K ﹤0.01%
26,300
-4,672
-15% -$25.7K

Similar funds

ProShare Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
  • ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
  • ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
  • ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
  • ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
  • ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
  • ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.